Literature DB >> 3001599

Dysfunction of central angiotensinergic aminopeptidase activity in spontaneously hypertensive rats.

J W Wright, M J Sullivan, J W Harding.   

Abstract

Alert spontaneously hypertensive (SH) rats, prepared with indwelling carotid artery catheters, demonstrated heightened and prolonged blood pressure (BP) responses to intracerebroventricular (i.c.v.) injections of 10 and 100 pmol angiotensin II and III (AII and AIII) as compared with Wistar-Kyoto (WKY) and Sprague-Dawley normotensive animals. Pretreatment with the aminopeptidase B inhibitor bestatin (10 nmol, i.c.v.) potentiated and prolonged the heightened pressor response to AIII (100 pmol, i.c.v.) in SH rats. These results suggest that dysfunction of angiotensin peptidase activity may be contributing to the progressive and sustained elevations in blood pressure noted to occur in the SH rat model of human essential hypertension.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3001599     DOI: 10.1016/0304-3940(85)90489-6

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  Developmental and ageing changes in aminopeptidase activities in selected tissues of the rat.

Authors:  M Ramírez; G Arechaga; B Sánchez; A Ozaita; P Lardelli
Journal:  Experientia       Date:  1993-04-15

2.  Distinct Molecular Effects of Angiotensin II and Angiotensin III in Rat Astrocytes.

Authors:  Michelle A Clark; Chinh Nguyen; Hieu Tran
Journal:  Int J Hypertens       Date:  2013-02-14       Impact factor: 2.420

3.  Focus on Brain Angiotensin III and Aminopeptidase A in the Control of Hypertension.

Authors:  John W Wright; Shigehiko Mizutani; Joseph W Harding
Journal:  Int J Hypertens       Date:  2012-06-26       Impact factor: 2.420

Review 4.  Aminopeptidase N in arterial hypertension.

Authors:  Robert S Danziger
Journal:  Heart Fail Rev       Date:  2007-11-16       Impact factor: 4.214

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.